Elsevier

Gene

Volume 298, Issue 1, 18 September 2002, Pages 9-19
Gene

Transcriptional repression of the RET proto-oncogene by a mitogen activated protein kinase-dependent signalling pathway

https://doi.org/10.1016/S0378-1119(02)00919-8Get rights and content

Abstract

Transcription factors play important roles in regulating cell growth and differentiation. In this study, treatment of the MTC cell line, TT, with phorbol 12-myristate 13-acetate (PMA) was shown to reduce neurite outgrowth which may be associated with de-differentiation and loss of the transformed phenotype. Northern blotting revealed that PMA transiently induced early growth response gene 1 (Egr-1) expression and decreased RET expression. Transient transfection analyses using 5′-deletion constructs of the basal RET promoter, demonstrated the requirement of a region between −70 and −33 bp for PMA-inducible expression. Gel shift and supershift studies demonstrated that PMA induced Egr-1 formed part of a complex capable of binding to the RET minimal promoter. Overexpression of Egr-1 displaced both sephacryl and phosphocellulose protein 1 (Sp1) and Sp3 from a GC-box element previously found to be important for RET basal expression. Furthermore, use of a raf-1 inducible TT cell line, that has been previously shown to downregulate RET expression, revealed that this downregulation may be linked to the induction of Egr-1. Our data suggest that regulation of RET expression during development and in medullary thyroid carcinoma may be determined, at least in part, by this complex of Sp and Egr-1 proteins.

Introduction

The RET proto-oncogene encodes a receptor tyrosine kinase required for the normal development of tissues derived from the neural crest and urogenital systems. Ligands which belong to the glial-cell line derived neurotrophic factor family form complexes with their glycosyl-phosphatidylinositol-anchored co-receptors and transduce their signal through RET (Saarma and Sariola, 1999). Constitutional RET mutations are associated with the multiple endocrine neoplasia type 2 syndrome (MEN 2) which is characterised by medullary thyroid carcinoma (MTC), a tumour originating in thyroid C-cells and the most frequent malignancy of MEN 2 (for review see Hansford and Mulligan, 2000).

During embryogenesis in both mouse and rat, ret is detected in neural crest cells which give rise to the thyroid C-cells, adrenal medulla, and intestinal autonomic ganglia (Pachnis et al., 1993). The temporal and spatial pattern of expression of this gene during development suggests that it is tightly regulated at the level of transcription. In adult tissues, the level of RET expression appears to be low to absent which may indicate that RET is transcriptionally silenced (Takaya et al., 1996). High levels of RET transcripts are detected in MTC (Santoro et al., 1990). The mechanism for the relatively high levels of RET expression, in the absence of obvious RET mutation in these specific tumour types, remains unclear. However, the relative levels of critical transcription factors required for RET expression and their state of activation in these different tissues may contribute to the transformation process.

The human RET proto-oncogene spans approximately 55 kb and has been shown to have a single transcription start site (Itoh et al., 1992, Andrew et al., 2000). The RET promoter is TATA-less and highly GC-rich (Itoh et al., 1992); (Andrew et al., 2000). A previous study from our laboratory has characterised RET basal promoter activity in the MTC cell line TT, and shown that it is dependent on sephacryl and phosphocellulose protein 1 (Sp1) and Sp3 binding within this region (Andrew et al., 2000). The highly GC-rich sequence of the RET proximal promoter suggested that methylation might account for the repression seen in most adult tissues. Surprisingly, analysis of this region failed to identify any methylation (Munnes et al., 1998). As Sp1 binding has been shown to prevent methylation in a number of promoters (Holler et al., 1988), a certain low level of expression of RET in most tissues may be achieved by the blocking of methylation by Sp1.

The Sp transcription factors are now thought to be part of a larger family of transcription factors containing a highly conserved DNA-binding domain (for review see Turner and Crossley, 1999). Specificity of individual members is achieved by their relative abundance within various cell types. For example, in primary keratinocytes, Sp3 levels exceed those of Sp1 but that ratio is reversed upon differentiation (Apt et al., 1996). Post-translational modification is also known to alter the affinity of Sp1 for its target sequence (Jackson et al., 1990). Interaction with other transcription factors, particularly those with overlapping cis sites, is another obvious source of specificity. Further study of the RET basal promoter sequence identified a potential recognition sequence for early growth response gene 1 (Egr-1), also known as Krox-24; Zif-268; Tis8 and NGF1-A. The Egr-1 site overlaps one of the Sp1 sites previously identified as necessary for basal transcription of RET (Andrew et al., 2000).

The Egr-1 transcription factor is a member of the immediate-early gene group, which includes c-fos and c-jun, and which exhibits de novo transcription within 30 min after mitogenic stimulation of a variety of cell types (Sukhatme et al., 1988). The Egr-1 gene encodes an 82 kDa protein which, like Sp1, contains three zinc finger motifs of the Cys2-His2 type. The consensus binding site for Egr-1 has been defined as 5′-GCGGGGGCG-3′ (Cao et al., 1993). Egr-1 can act either as a positive (Zhang et al., 2001) or negative (Bahouth et al., 2002) regulator of gene transcription, depending upon the presence and proximity of other DNA binding sites, because Egr-1 contains both transactivation and repression domains (Gashler et al., 1993). Overexpression of Egr-1 has been found to suppress transformed growth in a number of cell types (Huang et al., 1995). However, Egr-1 also has an important role in the normal differentiation of many cell types, and can be induced by factors which play a role in maintaining differentiation.

In MTC, silencing of RET expression has been associated with endocrine differentiation and a decrease in cell growth (Carson et al., 1995). Furthermore, this decrease in RET expression is associated with stimulation of Raf-1 in TT, a cell line derived from a patient with aggressive MTC (Carson et al., 1995). Phorbol 12-myristate 13-acetate (PMA), a known inducer of Egr-1, has been previously reported to promote differentiation in the TT cell line (deBustros et al., 1986). In this study, we have used luciferase reporter gene transfections and electrophoretic mobility shift analysis (EMSA) to further elucidate the molecular mechanisms responsible for RET expression in MTC. We demonstrate that a complex of proteins, including Sp1, Sp3, and Egr-1, bind to overlapping sites in the RET promoter to regulate RET expression.

Section snippets

Oligonucleotide synthesis, purification, and labelling

Oligonucleotides were synthesised by Pacific Oligos (Lismore, Australia). Double-stranded oligonucleotides were labelled with [γ-32P]-dATP (Amersham Pharmacia Biotech, Piscataway, NJ, USA) using T4 polynucleotide kinase (New England Biolabs, Beverly, MA) and purified using G-50 Sephadex columns (Amersham Pharmacia Biotech, Piscataway, NJ, USA).

Western blot analysis

Whole cell lysates were prepared by lysing with ice-cold phosphate buffered saline (PBS; 5.8 mM Na2HPO4, 1.7 mM NaH2PO4, 6.8 mM NaCl), containing 1%

PMA-induced alteration in cellular morphology

The MTC cell line TT, grows in monolayers and exhibits heterogeneity in cell size and shape (Leong et al., 1981). Treatment of TT cells with 10−8 M PMA caused a marked alteration in cellular morphology within 3 h. The cells adopted a pavement-like appearance, more normally associated with epithelial cells, and also exhibited partial retraction of neurites. This effect was maintained for at least 48 h in the presence of PMA. No morphological effect was seen with the vehicle control over the same

Discussion

The present study extends our previous findings that RET basal expression is controlled by the transactivators Sp1 and Sp3 in TT cells (Andrew et al., 2000). In this study, we suggest that induction of Egr-1 in TT cells by PMA represses RET expression by displacing the transactivators Sp1 and Sp3 from the minimal promoter. Several findings support this model. First, Egr-1 mRNA is induced in TT cells within minutes of exposure to PMA (Fig. 2D) preceding the appearance of complex C3 on the RET

Acknowledgements

We thank Dr V. Sukhatme (Beth Israel Hospital, Boston) for the Egr-1 cDNA probe, Dr E. Adamson for the recombinant Egr-1 and the Egr-1 expression vector (pCMV-Egr-1) and Dr C. Clarke for the 36B4 cDNA probe. DJM is a R.D. Wright Fellow (NH&MRC, Australia).

References (37)

  • V.P. Sukhatme et al.

    A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarisation

    Cell

    (1988)
  • J. Turner et al.

    Mammalian Kruppel-like transcription factors: more than just a pretty finger

    Trends Biochem. Sci.

    (1999)
  • T. Zhang et al.

    An early growth response protein (Egr) 1 cis-element is required for gonadotropin-releasing hormone-induced mitogen-activated protein kinase phosphatase 2 gene expression

    J. Biol. Chem.

    (2001)
  • S.W. Bahouth et al.

    Reciprocal regulation of beta(1)-adrenergic receptor gene transcription by Sp1 and early growth response gene 1: induction of EGR-1 inhibits the expression of the beta(1)-adrenergic receptor gene

    Mol. Pharmacol.

    (2002)
  • A. Calogero et al.

    The early growth response gene EGR-1 behaves as a suppressor gene that is down-regulated independent of ARF/Mdm2 but not p53 alterations in fresh human gliomas

    Clin. Cancer Res.

    (2001)
  • E.B. Carson et al.

    Ret gene silencing is associated with Raf-1-induced medullary thyroid carcinoma cell differentiation

    Cancer Res.

    (1995)
  • E.B. Carsonwalter et al.

    Post-transcriptional silencing of Ret occurs, but is not required, during Raf-1 mediated differentiation of medullary thyroid carcinoma cells

    Oncogene

    (1998)
  • I. de Belle et al.

    p53 and Egr-1 additively suppress transformed growth in HT1080 cells but Egr-1 counteracts p53-dependent apoptosis

    Oncogene

    (1999)
  • Cited by (18)

    • Transcriptional landscape of a RET<sup>C634Y</sup>-mutated iPSC and its CRISPR-corrected isogenic control reveals the putative role of EGR1 transcriptional program in the development of multiple endocrine neoplasia type 2A-associated cancers

      2018, Stem Cell Research
      Citation Excerpt :

      This enrichment is depicted on the multiomics circosplot RETC634Y IPSC samples away from RETwt and RETY634C iPSC and by clustering (Fig. 3C & 3D). The research of de novo motif for EGR1-dependent genomic intervals in the RETC634Y differential signature was used to check first that the EGR1 motifs were enriched, with 125 detected sites (Fig. 3E) and second that those same EGR1 related intervals were also predicted for other transcription factors such as HIF1A:ARNT, SP1 and SP3, MAX (Fig. 3F and Supplemental Fig. S3C) which have been implicated in RET transcriptional regulation in association with EGR1(Andrew et al., 2002), medullary thyroid carcinoma (Koperek et al., 2011) and pheochromocytoma (Huynh et al., 2006; Qin et al., 2014) pathophysiology. The molecular interactome of the EGR1 signature in RETC634Y IPSC involved connections with transcriptional coactivator modules such as EP300 and COPS as well as with transcription factors such as p53, JunB, YBX1(Supplemental Fig. 4D).

    • Lithium induces c-Ret expression in mouse inner medullary collecting duct cells

      2011, Cellular Signalling
      Citation Excerpt :

      In neural crest-derived tissues, many transcription factors such as Hoxb5, Ttf1, Nurr1, NKX2-1, Phox2b, Sox10, and Pax3 have been found to play crucial roles in regulating c-Ret transcription [11–14]. Additional studies have also identified a minimal promoter region rich in GC-islands that regulates c-Ret transcription through mechanisms involving Sp-family transcription factors under the influence of epigenetic processes on DNA methylation and histone acetylation [15–22]. In developing kidneys, c-Ret expression was found to be under the regulation of secreted ligands such as the stromal cell-derived retinoids [23,24] and the metanephric mesenchyme-derived GDNF, which not only activates the c-Ret kinase activity but also increases the expression of c-Ret mRNA [25].

    • Expression of NAG-1, a Transforming Growth Factor-β Superfamily Member, by Troglitazone Requires the Early Growth Response Gene EGR-1

      2004, Journal of Biological Chemistry
      Citation Excerpt :

      As shown in Fig. 5A, cotransfection of EGR-1 increased NAG-1 promoter activity after TGZ treatment, whereas Sp1 expression resulted in the reduction of NAG-1 promoter activity compared with empty vector transfection. Functional interplay between Sp1 and EGR-1 has been described for a number of human gene promoters (49, 52-54). The cis-acting element required for Sp1/EGR-1 binding is usually represented by a GC-rich sequence (GC box).

    • Ret Receptor Has Distinct Alterations and Functions in Breast Cancer

      2020, Journal of Mammary Gland Biology and Neoplasia
    View all citing articles on Scopus
    1

    Present address: Developmental Neurobiology Unit, Childrens’ Medical Research Institute, Westmead, NSW 2145, Australia.

    View full text